Algo version: 0.98b
ARWR is listed at the NASDAQ Exchange
ARWR [ARWR]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is ARWR stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

On Friday 21st of November 2014, Arrowhead Pharmaceuticals had a stock price of $5.90. If you invested back then, your return now would be a profit of $12.81 per share or 217.12%

Yes, the average daily trading liquidity for Arrowhead Pharmaceuticals is $23.10 million. You should therefore be able to get in and out of your positions relatively fast.

Arrowhead Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Arrowhead Pharmaceuticals to be high [0.85 out of 1]